Seelos Therapeutics Inc (SEEL) Annual Income Statement (USD)
SEEL Quarterly Financials (USD)
Frequently Asked Questions About Seelos Therapeutics Inc (SEEL) Stock
Seelos Therapeutics Inc's (SEEL) last reported annual revenue was USD 2.20 Million.
Seelos Therapeutics Inc's (SEEL) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Seelos Therapeutics Inc's(SEEL) is not profitable as of its last reported annual financials.
The net profit margin for Seelos Therapeutics Inc's(SEEL) from its laster reported year is -1719.56%
The return on equity (ROE) for Seelos Therapeutics Inc's(SEEL) from its last reported annual financials is : -584.20%
The return on assets (ROA) for Seelos Therapeutics Inc's(SEEL) from its last reported annual financials is : -179.75%
The return on invested capital (ROIC) for Seelos Therapeutics Inc's(SEEL) from its last reported annual financials is : 821.56%
The Debt to Equity ratio for Seelos Therapeutics Inc's(SEEL) from its last reported annual financials is : 0.00%
The dividend yield for Seelos Therapeutics Inc's(SEEL) from its laster reported year is 0.00%
Seelos Therapeutics Inc's(SEEL) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SEEL !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
